Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Clinical trial NCT05009082 · RECRUITING
Trial details
- NCT number
- NCT05009082
- Sponsor
- AGO Study Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2028-12-01
- Enrollment
- 970
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.